Apposite sells Cancer Partners UK

Apposite backed the creation of Cancer Partners UK in April 2006, providing venture financing to the company. Since then, Apposite has supported the company in building up the management team and financing the roll-out of eight cancer centres across the UK.

Company
Established in 2006, Cancer Partners UK provides radiotherapy treatments for cancer. The company focuses on up-to-date radiotherapy technologies and techniques.

Its radiotherapy centres are operated in partnership with private hospitals, located in Birmingham, Elstree, Guildford, Nottingham, Portsmouth and Southampton. The company also operates outpatient treatment centres in Milton Keynes and Oxford.

Cancer Partners UK employs 160 people.

People
David Porter is managing partner of Apposite and served on the company's board, alongside partner Steve Adkin. Steve Bird is CEO of Cancer Partners UK.

Advisers
Vendor – Rothschild (Corporate finance); Berwin Leighton Paisner (Legal).

• Tweet  
• Facebook  
• LinkedIn  
• Google plus  
• Send to  

• Topics
• UK / Ireland
• Exits
• Healthcare
• Apposite Capital
• United Kingdom